Skip to main content

Table 6 Reasons given for not taking part in a trial

From: Is it possible to estimate the minimal clinically important treatment effect needed to change practice in preterm birth prevention? Results of an obstetrician survey used to support the design of a trial

Trial

Reasons for not joining

 

Vaginal progesterone in

women with multiple

pregnancies

 

n = 85

 

Small numbers/rural

26 (30.6%)

 

Concerns re intervention

11 (12.9%)

 

Concerns re trial design

10 (11.8%)

 

Retiring soon

9 (10.6%)

 

Lack of resources

9 (10.6%)

 

Do not do research

6 (7.1%)

 

Not recorded

14 (16.5%)

IM progesterone in women

with singleton pregnancies with

risk factors for preterm birth

 

n = 119

 

Concerns re intervention

32 (26.9%)

 

Lack of resources

23 (19.3%)

 

Small numbers/rural

18 (15.1%)

 

Concerns re trial design

9 (7.6%)

 

Retiring soon

9 (7.6%)

 

Do not do research

4 (3.4%)

 

Sufficient evidence

2 (1.7%)

 

Not recorded

22 (18.5%)

Cerclage in women with risk

factors for preterm birth

 

n = 288

 

Concerns re intervention

110 (38.2%)

 

Sufficient evidence

38 (13.2%)

 

Do not do cerclage

32 (11.1%)

 

Concerns re trial design

28 (9.7%)

 

Small numbers/rural

21 (7.3%)

 

Lack of resources

10 (3.5%)

 

Retiring soon

8 (2.8%)

 

Do not do research

4 (1.4%)

 

Not recorded

37 (12.8%)